JSH practical guidelines for hematological malignancies, 2018: I. Leukemia—2. Acute promyelocytic leukemia (APL)

International Journal of Hematology volume 111, pages747–760(2020)Cite this article

This is a preview of subscription content, access via your institution.

Author information

Affiliations

  1. Department of Hematology, Saiseikai Yokohama Nanbu Hospital, 3-2-10 Konandai, Konan-ku, Yokohama, Kanagawa, 234-0054, Japan

    Hiroyuki Fujita

  2. Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan

    Yuichi Ishikawa

  3. Department of Hematology, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan

    Yasuhisa Yokoyama

Authors
  1. Hiroyuki Fujita
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuichi Ishikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yasuhisa Yokoyama
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroyuki Fujita.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Verify currency and authenticity via CrossMark

Cite this article

Fujita, H., Ishikawa, Y. & Yokoyama, Y. JSH practical guidelines for hematological malignancies, 2018: I. Leukemia—2. Acute promyelocytic leukemia (APL). Int J Hematol 111, 747–760 (2020). https://doi.org/10.1007/s12185-020-02884-z

Download citation